influenza
viru
fluav
infect
major
sourc
global
morbid
mortal
annual
influenza
epidem
claim
live
children
elderli
patient
compromis
immun
system
mainli
affect
moreov
intermitt
influenza
pandem
might
even
dramat
consequ
current
avail
vaccin
protect
season
influenza
need
reformul
annual
antivir
defens
pandem
fluav
antivir
drug
target
viral
protein
neuraminidas
na
avail
antivir
activ
compromis
resist
develop
particular
use
inhibitor
recommend
due
high
frequenc
viral
resist
therefor
novel
antivir
strategi
requir
provid
protect
fluav
host
cell
protein
essenti
viral
spread
dispens
surviv
cell
attract
target
novel
approach
antivir
intervent
sinc
blockad
might
associ
high
barrier
viral
resist
viral
surfac
protein
hemagglutinin
ha
mediat
bind
entri
fluav
host
cell
central
target
neutral
antibodi
ha
protein
synthes
inact
precursor
protein
constitut
secretori
pathway
infect
cell
depend
cleavag
host
cell
proteas
becom
activ
cleavageactiv
essenti
viral
infect
consequ
respons
proteas
potenti
target
antivir
intervent
specul
divers
secret
proteas
cleav
activ
ha
infect
host
howev
recent
studi
demonstr
singl
membraneassoci
enzym
unknown
physiolog
function
serin
proteas
cleav
activ
fluav
cell
cultur
essenti
spread
divers
fluav
mice
moreov
polymorph
found
associ
influenza
sever
human
patient
suggest
fluav
might
also
hijack
spread
human
host
howev
direct
proof
hypothesi
remain
provid
moreov
ttsp
identifi
human
sever
includ
hat
shown
express
lung
activ
ha
upon
direct
express
cell
cultur
potenti
contribut
proteas
viral
spread
host
larg
unclear
although
recent
studi
demonstr
virus
might
abl
exploit
jointli
spread
mice
experiment
infect
macaqu
fluav
result
viral
spread
influenza
symptom
usual
pronounc
observ
human
influenza
patient
nevertheless
infect
macaqu
highli
pathogen
fluav
pandem
viru
avian
influenza
virus
induc
sever
diseas
macaqu
model
success
use
vaccin
treatment
pathogenesisstudi
base
studi
suggest
macaqu
model
mirror
human
physiolog
develop
pneumonia
well
cytokin
chemokin
respons
close
anim
model
mice
ferret
recent
experiment
inocul
common
marmoset
fluav
also
describ
fluav
spread
transmiss
observ
model
anim
develop
sever
symptom
seen
human
patient
collect
nhp
valuabl
model
influenza
due
high
genet
similar
human
anim
may
best
suit
studi
depend
fluav
host
cell
factor
spread
pathogenesi
howev
current
unknown
whether
nhp
orthologu
relat
proteas
activ
fluav
whether
serin
proteas
activ
requir
fluav
spread
respiratori
epithelium
primat
show
hat
nhp
origin
cleav
activ
fluav
ha
subtyp
express
macaqu
respiratori
epithelium
moreov
demonstr
spread
fluav
subtyp
human
macaqu
marmoset
lung
tissu
block
serin
proteas
inhibitor
activ
express
plasmid
ha
asouth
human
hat
describ
previous
construct
plasmid
contain
nhp
orthologu
human
proteas
cdna
prepar
nhp
lung
tissu
proteas
sequenc
pcr
amplifi
clone
indic
tabl
human
embryon
kidney
hek
leibniz
institut
collect
microorgan
cell
cultur
cell
use
transfect
infect
experi
propag
dulbecco
modifi
eagl
medium
dmem
pan
mdck
cell
atcc
kindli
provid
k
schugart
hzi
braunschweig
use
focu
format
assay
grown
minimum
essenti
medium
mem
gibco
media
supplement
fetal
bovin
serum
fb
biochrom
penicillin
streptomycin
cell
maintain
humidifi
atmospher
contain
fluav
propag
chorioallanto
caviti
embryon
hen
egg
valo
biomedia
germani
h
previous
describ
viral
titer
determin
use
focu
format
assay
perform
exactli
previous
describ
nucleotid
amino
acid
sequenc
analyz
use
nucleotid
nt
blast
search
option
avail
via
server
ncbi
http
blastncbinlmnihgovblastcgi
align
amino
acid
sequenc
human
nhp
ttsp
construct
use
alignx
vector
nti
thermofish
analyz
express
human
hat
nhp
orthologu
cell
seed
plate
densiti
x
cellswel
cultiv
overnight
transfect
plasmid
encod
proteas
equip
ntermin
myc
tag
transfect
empti
plasmid
pcagg
control
analysi
ha
cleavag
cell
seed
plate
cotransfect
plasmid
encod
ha
proteas
empti
plasmid
control
h
post
transfect
cell
wash
pb
resuspend
sodium
dodecyl
sulfat
sd
load
buffer
heat
min
protein
separ
sdspolyacrylamid
gel
electrophoresi
page
blot
onto
nitrocellulos
membran
hartenstein
proteas
express
detect
use
mous
antimyc
antibodi
biomol
primari
antibodi
horseradish
peroxidas
hrp
coupl
antibodi
dianova
secondari
antibodi
fluav
ha
cleavag
detect
stain
goat
antifluav
polyclon
antibodi
millipor
hrpcoupl
antigoat
secondari
antibodi
dianova
express
detect
antibodi
sigma
aldrich
serv
load
control
prepar
precisioncut
lung
slice
pcl
perform
previous
describ
briefli
lung
lobe
human
lung
nhp
cannul
fill
prewarm
agaros
low
gell
temperatur
agaros
sigmaaldrich
cell
cultur
medium
mem
hepe
modif
sigmaaldrich
allow
solidifi
ice
human
macaqu
icecold
pb
common
marmoset
lung
lobe
separ
cut
punch
obtain
lung
tissu
contain
central
airway
pcl
diamet
mm
gener
employ
live
tissu
microtom
krumdieck
tissu
slicer
alabama
research
develop
pcl
transfer
hepe
phenol
red
medium
gibco
supplement
bsa
ps
medium
pcl
medium
well
plate
wash
three
time
everi
minut
immunohistochemistri
ihc
perform
use
dabmapkit
roch
thick
section
formalinfix
paraffin
embed
pcl
cell
condit
edta
antigen
retriev
solut
ph
section
load
discoveryxt
autostain
roch
deparaffin
rehydr
incub
antibodi
abcam
dilut
minut
follow
incub
secondari
antibodi
univers
secondari
antibodi
ventana
roch
minut
diaminobenzidin
ventanaview
dab
detect
kit
roch
appli
chromagen
accord
instruct
slide
counterstain
hematoxylin
blu
reagent
examin
light
microscopi
tissu
section
small
intestin
healthi
rhesu
macaqu
serv
posit
control
sampl
neg
control
stain
perform
omiss
primari
antibodi
immunohistochemistri
nhp
lung
anim
work
conduct
accord
relev
nation
intern
guidelin
particular
eu
direct
german
anim
protect
law
anim
welfar
ethic
committe
german
primat
center
approv
entir
studi
use
lung
materi
nhp
lung
origin
rhesu
macaqu
macaca
mulatta
cynomologu
macaqu
macaca
fasciculari
common
marmoset
callithrix
jacchu
german
primat
center
anim
euthan
author
veterinarian
anim
welfar
reason
ie
suffer
sever
trauma
aggress
group
conflict
automutil
marmoset
wast
syndrom
euthanasia
anim
deepli
anaesthet
use
combin
ketamin
pfizer
xylazin
bayer
macaqu
euthan
lethal
dose
sodium
pentobarbit
merial
gmbh
given
intraven
marmoset
euthan
lethal
dose
sodium
pentobarbit
merial
gmbh
given
intracardi
anim
healthi
respiratori
system
includ
studi
human
lung
human
lung
explant
obtain
patient
underw
lung
resect
cancer
pulmonari
hypertens
hospit
hanov
germani
hannov
medic
school
klinikum
siloah
nordstadt
patient
gave
written
consent
experiment
human
lung
tissu
approv
ethic
committe
hannov
medic
school
klinikum
region
hannov
lung
tissu
contain
tumor
qualifi
medic
pathologist
use
experi
tissu
process
immedi
day
resect
hen
egg
hen
egg
purchas
valo
biomedia
germani
h
inocul
viru
egg
euthan
overnight
incub
allanto
fluid
harvest
accord
tier
einem
entwicklungsstadium
experi
conduct
last
third
develop
anim
commenc
requir
approv
function
character
rhesu
cynomolgu
macaqu
well
marmoset
pcramplifi
respect
open
read
frame
lung
mrna
end
employ
rtpcr
oligonucleotid
base
sequenc
inform
avail
genbank
sequenc
encod
macaqu
hat
amplifi
analyz
comparison
pcr
product
clone
plasmid
pcagg
encod
protein
sequenc
found
ident
deposit
genbank
human
rhesu
macaqu
cynomolgu
macaqu
common
marmoset
human
rhesu
macaqu
cynomolgu
macaqu
human
hat
rhesu
macaqu
hat
cynomolgu
macaqu
hat
nhp
encod
orthologu
share
common
marmoset
rhesu
cynomolgu
sequenc
ident
human
amino
acid
level
encod
catalyt
triad
requir
proteas
activ
fig
similarli
rhesu
cynomolgu
hat
share
amino
acid
sequenc
ident
human
protein
nhp
orthologu
rhesu
cynomolgu
ident
human
counterpart
shown
next
ask
proteas
express
transfect
cell
proteas
equip
ntermin
mycantigen
tag
express
analyz
western
blot
gener
express
protein
robust
express
hat
protein
fig
human
nhp
orthologu
express
compar
level
similar
observ
made
contrast
express
human
hat
somewhat
reduc
compar
macaqu
orthologu
fig
ttsp
synthes
inactiv
precursor
zymogen
undergo
autocatalyt
activ
inde
band
molecular
weight
expect
zymogen
form
activ
product
hat
detect
fig
suggest
enzym
activ
cell
collect
nhp
orthologu
hat
share
high
sequenc
ident
human
counterpart
express
activ
transfect
cell
next
investig
whether
hat
nhp
origin
cleav
fluavha
treatment
ha
express
cell
trypsin
result
cleavag
ha
precursor
evidenc
appear
subunit
fig
keep
expect
similarli
coexpress
human
well
nhp
counterpart
facilit
robust
compar
ha
cleavag
process
ha
human
hat
also
readili
detect
macaqu
orthologu
enzym
show
reduc
ha
cleavag
fig
despit
increas
express
rel
human
enzym
final
noteworthi
trypsin
produc
ident
band
fragment
gener
trypsin
differ
molecular
weight
fig
differ
previous
report
found
due
differenti
nglycosyl
fragment
next
determin
ha
cleavag
result
activ
proteas
express
cell
cell
infect
infecti
unit
present
cultur
supernat
h
post
infect
determin
proteas
endogen
express
cell
fail
activ
ha
therefor
viru
spread
absenc
trypsin
within
background
level
spread
presenc
trypsin
effici
fig
express
human
nhp
origin
allow
robust
spread
absenc
trypsin
similar
observ
made
hat
fig
thu
hat
nhp
origin
cleav
activ
ha
light
pivot
role
fluav
spread
mice
next
examin
whether
protein
express
macaqu
lung
tissu
whether
inhibitor
block
viral
spread
tissu
employ
pcl
nhp
origin
immunohistochemistri
conduct
antibodi
rais
human
crossreact
macaqu
orthologu
reveal
brown
color
robustli
express
bronchiolar
epitheli
cell
subepitheli
alveolar
macrophag
fig
camostat
serin
proteas
inhibitor
activ
afford
opportun
investig
whether
fluav
spread
human
nonhuman
primat
pcl
depend
serin
proteas
activ
fluav
spread
pcl
human
nhp
origin
gener
effici
suscept
inhibit
camostat
absenc
cytotox
effect
fig
determin
cytotox
detect
kit
plu
ldh
shown
howev
subtl
differ
effici
fluav
inhibit
camostat
note
thu
blockad
viral
spread
common
marmoset
pcl
effici
camostat
reduc
fluav
spread
background
level
concentr
inhibitor
modest
inhibitori
effect
pcl
human
cynomolgu
macaqu
origin
fail
block
viral
spread
rhesu
macaqu
pcl
fig
thu
express
macaqu
respiratori
epithelium
serin
proteas
activ
requir
fluav
spread
lung
tissu
human
macaqu
marmoset
origin
constantli
accumul
bodi
evid
suggest
exploit
fluav
spread
thu
direct
endogen
express
cell
cultur
shown
activ
fluav
ha
proteas
found
express
receptorposit
cell
human
aerodigest
tract
moreov
sever
studi
report
express
requir
spread
pathogenesi
divers
fluav
mice
furthermor
inactiv
gene
mice
compat
normal
develop
homeostasi
indic
dispens
cellular
organism
surviv
thu
attract
drug
target
howev
contribut
viral
spread
human
nhp
less
well
understood
show
macaqu
marmoset
orthologu
cleav
activ
fluav
ha
express
rhesu
macaqu
respiratori
epithelium
moreov
demonstr
fluav
spread
human
macaqu
marmoset
respiratori
epithelium
block
serin
proteas
inhibitor
activ
result
suggest
macaqu
might
suitabl
model
usag
fluav
human
member
ttsp
famili
show
conserv
domain
organ
ntermin
domain
locat
cytoplasm
follow
transmembran
domain
stem
region
proteas
domain
enzym
synthes
zymogen
constitut
secretori
pathway
autocatalyt
activ
cleavag
stem
region
proteas
domain
enzym
encod
nhp
origin
exhibit
amino
acid
sequenc
ident
human
counterpart
includ
presenc
catalyt
triad
locat
proteas
domain
essenti
enzymat
activ
similar
observ
made
nhp
ortholog
hat
moreov
test
proteas
readili
express
transfect
cell
evid
autoactiv
cell
obtain
therefor
unexpect
hat
orthologu
nhp
origin
abl
cleav
activ
ha
whether
subtl
differ
activ
effici
observ
marmoset
orthologu
test
translat
differenti
ha
activ
infect
host
present
unknown
previou
analysi
demonstr
coexpress
sialic
acid
major
receptor
determin
human
fluav
larg
part
human
respiratori
gastrointestin
epithelium
express
detect
human
bronchiolar
epithelium
present
studi
indic
substanti
level
also
produc
bronchiolar
epitheli
cell
rhesu
macaqu
howev
potenti
differ
cell
type
specif
express
human
nhp
respiratori
tissu
present
exclud
thu
previous
detect
protein
mainli
type
ii
pneumocyt
within
human
tissu
sampl
cell
target
fluav
contrast
matsuyama
colleagu
found
predominantli
express
type
pneumocyt
healthi
cynomolgu
macaqu
although
context
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
detect
viral
antigen
protein
type
ii
pneumocyt
find
relat
serin
proteas
activ
fluav
ha
upon
direct
express
cell
cultur
endogen
express
bronchiolar
epithelium
within
pcl
trigger
question
whether
serin
proteas
activ
requir
fluav
spread
human
nhp
pcl
address
question
employ
serin
proteas
inhibitor
camostat
sinc
compound
previous
shown
block
viral
activ
absenc
unwant
cytotox
sinc
pcl
amen
extens
manipul
includ
transfect
sirna
camostat
markedli
dosedepend
reduc
fluav
spread
pcl
human
macaqu
marmoset
origin
without
induc
cytotox
effect
keep
recent
data
show
camostat
inhibit
fluav
replic
cytokin
product
cultur
human
tracheal
epitheli
cell
thu
fluav
depend
activ
serin
proteas
potenti
spread
human
nhp
respiratori
tissu
although
state
exclus
virus
subtyp
test
present
studi
exclud
proteas
choic
subtyp
may
differ
collect
result
indic
nhp
orthologu
human
relat
proteas
activ
ha
macaqu
serv
model
investig
proteasedepend
fluav
spread
